Report Detail
Global Ivosidenib Market Insights, Forecast to 2025
- RnM3447657 |
- 22 May, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Ivosidenib market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ivosidenib market based on company, product type, end user and key regions.
This report studies the global market size of Ivosidenib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ivosidenib in these regions.
This research report categorizes the global Ivosidenib market by top players/brands, region, type and end user. This report also studies the global Ivosidenib market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Agios Pharmaceuticals
Market size by Product
60 Tablets
30 Tablets
Market size by End User
Hospital
Pharmacy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Ivosidenib market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ivosidenib market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ivosidenib companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ivosidenib submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Ivosidenib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ivosidenib market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Ivosidenib Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Ivosidenib Market Size Growth Rate by Product
- 1.4.2 60 Tablets
- 1.4.3 30 Tablets
- 1.5 Market by End User
- 1.5.1 Global Ivosidenib Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Ivosidenib Market Size
- 2.1.1 Global Ivosidenib Revenue 2014-2025
- 2.1.2 Global Ivosidenib Sales 2014-2025
- 2.2 Ivosidenib Growth Rate by Regions
- 2.2.1 Global Ivosidenib Sales by Regions
- 2.2.2 Global Ivosidenib Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Ivosidenib Sales by Manufacturers
- 3.1.1 Ivosidenib Sales by Manufacturers
- 3.1.2 Ivosidenib Sales Market Share by Manufacturers
- 3.1.3 Global Ivosidenib Market Concentration Ratio (CR5 and HHI)
- 3.2 Ivosidenib Revenue by Manufacturers
- 3.2.1 Ivosidenib Revenue by Manufacturers (2014-2019)
- 3.2.2 Ivosidenib Revenue Share by Manufacturers (2014-2019)
- 3.3 Ivosidenib Price by Manufacturers
- 3.4 Ivosidenib Manufacturing Base Distribution, Product Types
- 3.4.1 Ivosidenib Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Ivosidenib Product Type
- 3.4.3 Date of International Manufacturers Enter into Ivosidenib Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Ivosidenib Sales by Product
- 4.2 Global Ivosidenib Revenue by Product
- 4.3 Ivosidenib Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Ivosidenib Breakdown Data by End User
6 North America
- 6.1 North America Ivosidenib by Countries
- 6.1.1 North America Ivosidenib Sales by Countries
- 6.1.2 North America Ivosidenib Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Ivosidenib by Product
- 6.3 North America Ivosidenib by End User
7 Europe
- 7.1 Europe Ivosidenib by Countries
- 7.1.1 Europe Ivosidenib Sales by Countries
- 7.1.2 Europe Ivosidenib Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Ivosidenib by Product
- 7.3 Europe Ivosidenib by End User
8 Asia Pacific
- 8.1 Asia Pacific Ivosidenib by Countries
- 8.1.1 Asia Pacific Ivosidenib Sales by Countries
- 8.1.2 Asia Pacific Ivosidenib Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Ivosidenib by Product
- 8.3 Asia Pacific Ivosidenib by End User
9 Central & South America
- 9.1 Central & South America Ivosidenib by Countries
- 9.1.1 Central & South America Ivosidenib Sales by Countries
- 9.1.2 Central & South America Ivosidenib Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Ivosidenib by Product
- 9.3 Central & South America Ivosidenib by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Ivosidenib by Countries
- 10.1.1 Middle East and Africa Ivosidenib Sales by Countries
- 10.1.2 Middle East and Africa Ivosidenib Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Ivosidenib by Product
- 10.3 Middle East and Africa Ivosidenib by End User
11 Company Profiles
- 11.1 Agios Pharmaceuticals
- 11.1.1 Agios Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Agios Pharmaceuticals Ivosidenib Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Agios Pharmaceuticals Ivosidenib Products Offered
- 11.1.5 Agios Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Ivosidenib Market Forecast by Regions
- 12.1.1 Global Ivosidenib Sales Forecast by Regions 2019-2025
- 12.1.2 Global Ivosidenib Revenue Forecast by Regions 2019-2025
- 12.2 Ivosidenib Market Forecast by Product
- 12.2.1 Global Ivosidenib Sales Forecast by Product 2019-2025
- 12.2.2 Global Ivosidenib Revenue Forecast by Product 2019-2025
- 12.3 Ivosidenib Market Forecast by End User
- 12.4 North America Ivosidenib Forecast
- 12.5 Europe Ivosidenib Forecast
- 12.6 Asia Pacific Ivosidenib Forecast
- 12.7 Central & South America Ivosidenib Forecast
- 12.8 Middle East and Africa Ivosidenib Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Ivosidenib Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Ivosidenib . Industry analysis & Market Report on Ivosidenib is a syndicated market report, published as Global Ivosidenib Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ivosidenib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
